Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EPRX advanced for three days, in 100 of 123 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on EPRX as a result. In 57 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for EPRX just turned positive on October 22, 2026. Looking at past instances where EPRX's MACD turned positive, the stock continued to rise in 29 of 39 cases over the following month. The odds of a continued upward trend are 74%.
EPRX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for EPRX moved above the 200-day moving average on October 05, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
EPRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 92 of 132 cases where EPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.
The 10-day RSI Indicator for EPRX moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for EPRX crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.642) is normal, around the industry mean (2.973). P/E Ratio (-7.441) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. EPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The 50-day moving average for TARS moved above the 200-day moving average on September 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 48 cases where TARS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where TARS advanced for three days, in 229 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
TARS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TARS as a result. In 70 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
TARS moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TARS crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for TARS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.727) is normal, around the industry mean (2.973). TARS has a moderately low P/E Ratio (-67.364) as compared to the industry average of (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.498) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. TARS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TARS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 22 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 75 | |
SEASONALITY SCORE 1..100 | 14 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| EPRX | TARS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 89% | N/A |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 74% | N/A |
| TrendWeek ODDS (%) | 1 day ago 53% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 63% | 1 day ago 81% |
| Advances ODDS (%) | 2 days ago 81% | 3 days ago 80% |
| Declines ODDS (%) | 9 days ago 74% | 7 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 70% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EPRX’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EPRX’s TA Score shows that 7 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).
EPRX (@Biotechnology) experienced а +12.11% price change this week, while TARS (@Biotechnology) price change was +1.54% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
EPRX is expected to report earnings on Nov 03, 2026.
TARS is expected to report earnings on Nov 03, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with IMNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then IMNM could also see price increases.
| Ticker / NAME | Correlation To EPRX | 1D Price Change % | ||
|---|---|---|---|---|
| EPRX | 100% | -1.81% | ||
| IMNM - EPRX | 35% Loosely correlated | +1.44% | ||
| ASMB - EPRX | 35% Loosely correlated | -0.88% | ||
| LKFT - EPRX | 33% Loosely correlated | +2.68% | ||
| EDIT - EPRX | 33% Loosely correlated | -0.80% | ||
| TARS - EPRX | 33% Loosely correlated | +2.24% | ||
More | ||||
A.I.dvisor indicates that over the last year, TARS has been loosely correlated with PTGX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then PTGX could also see price increases.
| Ticker / NAME | Correlation To TARS | 1D Price Change % | ||
|---|---|---|---|---|
| TARS | 100% | +2.24% | ||
| PTGX - TARS | 44% Loosely correlated | +1.05% | ||
| IONS - TARS | 40% Loosely correlated | -0.81% | ||
| ARVN - TARS | 39% Loosely correlated | +2.18% | ||
| IMNM - TARS | 38% Loosely correlated | +1.44% | ||
| BCYC - TARS | 38% Loosely correlated | +1.96% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VDIG | 65.31 | 0.07 | +0.11% |
| Vanguard Wellington Dividend Growth Active ETF (VDIG) | |||
| ACSI | 76.13 | N/A | N/A |
| American Customer Satisfaction ETF (ACSI) | |||
| EDD | 5.36 | -0.09 | -1.65% |
| Morgan Stanley Emerging Markets Domestic Debt Fund | |||
| DUKX | 27.50 | -0.49 | -1.74% |
| Ocean Park International ETF (DUKX) | |||
| ROBO | 74.84 | -2.71 | -3.49% |
| ROBO Global Robotics & Automation Index ETF (ROBO) | |||